This study is a prospective, single-center, single-arm pilot trial. The primary research question is whether brief, breath control-focused Acceptance and Commitment Therapy (ACT) is feasible, acceptable, and safe in adults with chronic cough.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Recruitment rate
Timeframe: From screening and recruitment to enrollment
Retention rate
Timeframe: From enrollment to the end of treatment at 4 weeks
Adherence rate of session attendance
Timeframe: From enrollment to the end of treatment at 4 weeks
Ordinal scale of adherence to self-directed activities
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for cough-related adherence barriers
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for acceptability
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for appropriateness
Timeframe: From enrollment to the end of treatment at 4 weeks
Likert scale of agreement for burden
Timeframe: From enrollment to the end of treatment at 4 weeks
Carolyn K. Novaleski, Ph.D., CCC-SLP
Distress Questionnaire-5 (DQ5)
Timeframe: From enrollment to the end of treatment at 4 weeks
Binary scale for monitoring program-specific psychological distress
Timeframe: From enrollment to the end of treatment at 4 weeks
Adverse events (AEs)
Timeframe: From enrollment to the end of treatment at 4 weeks